MedTrace Logo

Tissue Kallikrein Protect Against Ischemic Stroke

NCT06422572 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8602

Last updated 2024-05-21

No results posted yet for this study

Summary

The results of previous studies were used to assess the causal association between TK levels and stroke occurrence at 5 and 12 years of follow-up, respectively.

Conditions

  • Stroke, Ischemic

Interventions

OTHER

No Intervention

No Intervention

Sponsors & Collaborators

  • National Natural Science Foundation of China

    collaborator OTHER_GOV

  • Qin Zhang

    lead OTHER

Principal Investigators

  • QIN Zhang, phd · Tongji Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2023-12-30
Completion
2023-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06422572 on ClinicalTrials.gov